Literature DB >> 9266891

Airway inflammation in COPD assessed by sputum levels of interleukin-8.

C Yamamoto1, T Yoneda, M Yoshikawa, A Fu, T Tokuyama, K Tsukaguchi, N Narita.   

Abstract

STUDY
OBJECTIVE: To assess the characteristics of airway inflammation in patients with COPD.
METHODS: We measured the sputum concentration of interleukin-8 (IL-8), a chemokine involved in the migration and activation of neutrophils and eosinophils. We also measured myeloperoxidase (MPO) as a parameter of neutrophil activity and eosinophil cationic protein (ECP) as a parameter of eosinophil activity. Spontaneous sputum samples were obtained from 33 patients with stable COPD and 30 patients with asthma. Induced sputum samples were obtained from 12 normal control subjects.
RESULTS: The sputum concentration of IL-8 was significantly higher in the patients with COPD than in the patients with asthma or in the control subjects (p<0.0001). Concentrations of MPO and ECP were significantly higher in the patients with COPD than in the control subjects but did not differ significantly between the patients with COPD and those with asthma. In the patients with COPD, the sputum concentration of IL-8 was significantly correlated with the concentration of MPO (r=0.55, p<0.001) and of ECP (r=0.53, p<0.01). The sputum concentration of IL-8 was negatively correlated with FEV1/FVC (r=-0.78, p<0.0001) in the COPD group.
CONCLUSIONS: Results suggest the activation of both neutrophils and eosinophils in the airways of patients with COPD. It appears that IL-8 plays a primary role in this activation. The sputum concentration of IL-8 appeared to be closely associated with the degree of airflow obstruction in patients with COPD and may serve as a marker in evaluating the severity of airway inflammation, which is a risk factor for COPD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266891     DOI: 10.1378/chest.112.2.505

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  71 in total

Review 1.  Factors influencing airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Hill; S Gompertz; R Stockley
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 2.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

3.  Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease.

Authors:  M Zhang; Q Li; X-Y Zhang; X Ding; D Zhu; X Zhou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-20       Impact factor: 3.267

Review 4.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

5.  Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease.

Authors:  Evelyn Tsantikos; Maverick Lau; Cassandra Mn Castelino; Mhairi J Maxwell; Samantha L Passey; Michelle J Hansen; Narelle E McGregor; Natalie A Sims; Daniel P Steinfort; Louis B Irving; Gary P Anderson; Margaret L Hibbs
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

6.  Evaluation of IL-8 nasal lavage levels and the effects of nasal involvement on disease severity in patients with stable chronic obstructive pulmonary disease.

Authors:  Hacer Celik; Serdar Akpinar; Hayriye Karabulut; Pinar Oktar; Berna Dursun; Huyla Celenk Erguden; Sibel Gunay; Tugrul Sipit
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

7.  Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.

Authors:  H J Metcalfe; S Lea; D Hughes; R Khalaf; K Abbott-Banner; D Singh
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 8.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Tumor necrosis factor alpha as a marker of systemic and local inflammation in "healthy" smokers.

Authors:  Juan M Diez-Pina; María J Fernandez-Aceñero; María J Llorente-Alonso; Salvador Diaz-Lobato; Sagrario Mayoralas; Asuncion Florez
Journal:  Int J Gen Med       Date:  2009-07-30

10.  PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.

Authors:  Sara S Roscioni; Loes E M Kistemaker; Mark H Menzen; Carolina R S Elzinga; Reinoud Gosens; Andrew J Halayko; Herman Meurs; Martina Schmidt
Journal:  Respir Res       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.